New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
10:02 EDTCMRE, A, MM, KBIO, EDAP, ZFC, SUPN, SRPT, NSLP, NFLX, ISRG, HIIQ, EOPN, DYAX, ANTH, CACC, AEGR, AYI, MITTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AG Mortgage (MITT) initiated with a Neutral at Credit Suisse... Acuity Brands (AYI) initiated with a Buy at UBS... Aegerion (AEGR) initiated with a Buy at BofA/Merrill... Anthera Pharmaceuticals (ANTH) initiated with a Buy at Jefferies... Credit Acceptance (CACC) initiated with an Outperform at JMP Securities... Diana Shipping (DSX) initiated with a Neutral at JPMorgan... Dyax (DYAX) initiated with a Buy at Jefferies... E2open (EOPN) initiated with a Buy at Benchmark Co.... Health Insurance Innovations (HIIQ) initiated with an Outperform at Credit Suisse... Intuitive Surgical (ISRG) initiated with an Underperform at Northland Securities... Netflix (NFLX) initiated with an Outperform at RBC Capital... New Source Energy (NSLP) initiated with an Outperform at RW Baird... Sarepta (SRPT) initiated with an Outperform at Leerink... Supernus Pharmaceuticals (SUPN) initiated with a Buy at Jefferies... ZAIS Financial (ZFC) initiated with a Buy at Citigroup, initiated with an Outperform at Credit Suisse and initiated with an Overweight at Barclays... EDAP TMS (EDAP) initiated with an Outperform at Northland Securities... Health Insurance Innovations (HIIQ) initiated with a Strong Buy at Raymond James... KaloBios (KBIO) initiated with a Buy at Needham... Millennial Media (MM) initiated with a Hold at Needham... ZAIS Financial (ZFC) initiated with a Perform at Oppenheimer... Agilent (A) initiated with an Outperform at Credit Suisse... Costamare (CMRE) initiated with an Overweight at JPMorgan.
News For MITT;AYI;AEGR;CACC;ANTH;DYAX;EOPN;HIIQ;ISRG;NFLX;NSLP;SRPT;SUPN;ZFC;EDAP;KBIO;MM;A;CMRE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
October 8, 2014
15:43 EDTNFLXNetflix October weekly volatility low at 21
Subscribe for More Information
15:25 EDTEOPNNotable companies reporting after market close
Subscribe for More Information
11:22 EDTSRPTChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
10:00 EDTCACCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:48 EDTNFLXGoogle says new movies can be pre-ordered, watched on first day of availibility
Subscribe for More Information
09:38 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:02 EDTNFLXNetflix November volatility increases into Q3 and outlook
Netflix October call option implied volatility is at 58, November is at 40, December is at 33, January is at 31, March is at 32; compared to its 26-week average of 35, suggesting large near term price movement into the expected release of Q3 results on October 15.
07:16 EDTCACCCredit Acceptance initiated with a Neutral at Macquarie
Subscribe for More Information
October 7, 2014
16:10 EDTCACCCredit Acceptance announces certain operating results related to tender offer
Credit Acceptance announced certain operating results in connection with our previously announced tender offer to purchase up to 995,698 shares of our outstanding common stock at a price of $125.54 per share. The tender offer will expire at 5:00 p.m., New York City time, on Monday, October 20, unless extended. Company announced among other highlights "Consumer Loans assigned in 2009 through 2013 have yielded forecasted collection results materially better than our initial estimates, while Consumer Loans assigned in 2006 and 2007 have yielded forecasted collection results materially worse than our initial estimates. For all other assignment years presented, actual results have been very close to our initial estimates. For the two months ended August 31, 2014, forecasted collection rates improved for Consumer Loans assigned in 2013 and 2014 and were generally consistent with expectations at the start of the period for all other assignment years presented".
16:00 EDTNFLXOptions Update; October 7, 2014
iPath S&P 500 VIX Short-Term Futures up 2.16 to 32.24 Option volume leaders: AAPL TSLA TWTR AMZN FB VZ AA HTZ NFLX PBR according to Track Data.
09:36 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:22 EDTEDAPEDAP TMS announces sale of Focal One HIFU device to Mannheim University Hospital
EDAP TMS announced the first successful treatments performed at Germany's Mannheim University Hospital, or UMM, using the company's Focal One HIFU device. UMM is home to one of the largest urological Centers in Germany, with more than 4,000 patients treated annually. The Department of Urology at UMM is headed by prominent urologist Pr. M.S. Michel, also Chairman of the Academy of German Urologists. The UMM Urology Department is a large certified prostate cancer center, offering the most advanced innovative imaging and therapeutic technologies to address prostate cancer.
October 6, 2014
16:00 EDTNFLXOptions Update; October 6, 2014
iPath S&P 500 VIX Short-Term Futures up 46c to 30.08. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX HPQ C RSH CLF PBR according to Track Data.
11:25 EDTISRGIntuitive Surgical volatility increases on rally after Goldman upgrades
Subscribe for More Information
11:17 EDTISRGIntuitive Surgical climbs after Goldman ups to Buy
Subscribe for More Information
10:41 EDTISRGIntuitive Surgical rises, levels to watch
At time of writing the shares were up over 3.9% to $493.83, well down from the session high at $505.74 which is resistance. At current price support is at the session low at $489.32, the opening price of the day. Goldman earlier upgraded the shares to a Buy, with a $584 price target.
10:04 EDTISRGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
06:18 EDTNSLPNew Source Energy files $50M equity distribution agreement with BMO Capital
Subscribe for More Information
05:22 EDTISRGIntuitive Surgical upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Intuitive Surgical (ISRG) to Buy citing an improving hospital spending environment and long-term uptake of surgery procedures in the U.S. The firm raised its price target for shares to $584 from $466. Shares of the robotic surgery maker closed Friday at $475.21.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use